Table 2.
Expression Values of LPARs After Gintonin Administration
Receptor | Organs |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Brain |
Heart |
Lung |
Liver |
Kidney |
|||||||
Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | ||
LPA1 | Con | 0.045 ± 0.011 | 2.4 ↓ | 0.004 ± 0.001 | 32 ↑ | 0.001 ± 0.000 | 39 ↑ | ND | ND | 0.071 ± 0.060 | 0 ↓ |
GT | 0.018 ± 0.006∗ | 0.143 ± 0.072∗ | 0.044 ± 0.015∗ | ND | 0.000 ± 0.000 | ||||||
LPA2 | Con | 0.040 ± 0.037 | 1.8 ↓ | 0.090 ± 0.076 | 3 ↑ | 0.116 ± 0.041 | 2.3 ↓ | 0.618 ± 0.382 | 0 ↓ | 0.043 ± 0.024 | 0 ↓ |
GT | 0.020 ± 0.020 | 0.278 ± 0.239 | 0.050 ± 0.050 | 0.000 ± 0.000 | 0.000 ± 0.000 | ||||||
LPA3 | Con | 0.039 ± 0.037 | 5 ↑ | 0.022 ± 0.018 | 1.4 ↑ | 0.085 ± 0.056 | 4.5 ↑ | 0.329 ± 0.289 | 1.4 ↑ | 0.329 ± 0.289 | 1.4 ↑ |
GT | 0.200 ± 0.184 | 0.030 ± 0.030 | 0.382 ± 0.280 | 0.478 ± 0.294 | 0.478 ± 0.294 | ||||||
LPA4 | Con | 0.168 ± 0.092 | 1.8 ↑ | 0.135 ± 0.082 | 3.9 ↑ | 0.019 ± 0.010 | 4 ↑ | ND | ND | 0.150 ± 0.150 | 0 ↓ |
GT | 0.302 ± 0.147 | 0.529 ± 0.332 | 0.077 ± 0.028∗ | ND | 0.000 ± 0.000 | ||||||
LPA5 | Con | 0.002 ± 0.001 | 0 ↓ | 0.003 ± 0.002 | 0 ↓ | 0.004 ± 0.004 | 25 ↑ | ND | ND | ND | ND |
GT | 0.000 ± 0.000 | 0.000 ± 0.000 | 0.094 ± 0.049∗ | ND | ND | ||||||
LPA6 | Con | 1.176 ± 0.344 | 8.7 ↓ | 6.597 ± 0.801 | 3.4 ↓ | 3.952 ± 0.882 | 1.4 ↓ | 9.589 ± 1.709 | 8.5 ↑ | 3.339 ± 0.074 | 1.1 ↓ |
GT | 0.135 ± 0.057∗ | 1.918 ± 0.442∗ | 2.777 ± 1.397 | 81.12 ± 11.000∗ | 2.925 ± 1.091 |
Receptor | Organs |
||||||||
---|---|---|---|---|---|---|---|---|---|
Spleen |
Small Intestine |
Colon |
Testis |
||||||
Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | Mean ± SEM | Fold changes | ||
LPA1 | Con | 0.001 ± 0.001 | 40 ↑ | 0.022 ± 0.020 | 14 ↑ | 0.024 ± 0.021 | 1.1 ↓ | 0.080 ± 0.032 | 3 ↑ |
GT | 0.073 ± 0.028∗ | 0.314 ± 0.167∗ | 0.021 ± 0.010 | 0.243 ± 0.222 | |||||
LPA2 | Con | ND | ND | 0.677 ± 0.085 | 1.5 ↓ | ND | ND | 0.056 ± 0.045 | 0 ↓ |
GT | ND | 0.427 ± 0.422 | ND | 0.000 ± 0.000 | |||||
LPA3 | Con | 0.401 ± 0.236 | 1.5 ↓ | 0.125 ± 0.087 | 5.1 ↑ | 0.145 ± 0.126 | 6.7 ↓ | 0.377 ± 0.212 | 1.8 ↑ |
GT | 0.252 ± 0.252 | 0.635 ± 0.464 | 0.022 ± 0.017 | 0.698 ± 0.365 | |||||
LPA4 | Con | 0.035 ± 0.017 | 9 ↑ | 0.001 ± 0.001 | 581 ↑ | ND | ND | 0.016 ± 0.016 | 15 ↑ |
GT | 0.324 ± 0.070 | 0.499 ± 0.257∗ | 0.595 ± 0.203∗ | 0.243 ± 0.122∗ | |||||
LPA5 | Con | 0.056 ± 0.054 | 0 ↓ | 0.121 ± 0.105 | 1.4 ↑ | ND | ND | 0.109 ± 0.081 | 0 ↓ |
GT | 0.000 ± 0.000 | 0.169 ± 0.103 | ND | 0.000 ± 0.000 | |||||
LPA6 | Con | 0.392 ± 0.045 | 1.8 ↑ | 0.535 ± 0.079 | 4.8 ↑ | 0.612 ± 0.067 | 2.6 ↑ | 0.334 ± 0.060 | 11.8 ↑ |
GT | 0.723 ± 0.476 | 2.595 ± 0.887∗ | 1.604 ± 0.765 | 3.939 ± 1.066∗ |
ND: Not detected in two groups.
↓: Tendency to decrease in gintonin-treated group.
↑: Tendency to increase in gintonin-treated group.
∗p < 0.05 vs control.